natgillin/translations-raw huggingface dataset:
ob upoštevanju sporočila Komisije z dne 27. aprila 2005 z naslovom "Evropski akcijski program za boj proti HIV/aidsu, malariji in tuberkulozi s pomočjo zunanjih ukrepov (2007-2011)" ( KOM(2005)0179 ),
having regard to the Commission communication of 27 April 2005 entitled "A European Programme for Action to Confront HIV/AIDS, Malaria and Tuberculosis through External Action (2007-2011)" ( COM(2005)0179 ),
ob upoštevanju sporočila Komisije z dne 26. oktobra 2004 z naslovom "Podlaga skladne evropske politike za zunanje ukrepe v boju proti boleznim HIV/AIDS, malarija in tuberkuloza" ( KOM(2004)0726 ),
having regard to the Commission communication of 26 October 2004 entitled "A Coherent European Policy Framework for External Action to Confront HIV/AIDS, Malaria and Tuberculosis" ( COM(2004)0726 ),
ob upoštevanju svojih resolucij o HIV/aidsu, malariji in tuberkulozi, zlasti tiste z dne 4. oktobra 2001 o pospešenem ukrepanju v boju proti glavnim nalezljivim boleznim v okviru zmanjševanja revščine
having regard to its resolutions on HIV/AIDS, malaria, and tuberculosis, in particular that of 4 October 2001 on accelerated action targeted at major communicable diseases within the context of poverty reduction
UL C 87 E, 11.4.2002, str.
OJ C 87 E, 11.04.2002, p.
ob upoštevanju svoje resolucije z dne 30. januarja 2003 o predlogu Uredbe o pomoči za bolezni, povezane z revščino (HIV/aids, malarija in tuberkoloza) v državah v razvoju UL C 39 E, 13.2.2004, str.
having regard to its resolution of 30 January 2003 on the proposal for a regulation on aid for poverty diseases (HIV/AIDS, malaria and tuberculosis) in developing countries OJ C 39 E, 13.2.2004, p.
ob upoštevanju okvirne konvencije Svetovne zdravstvene organizacije (WHO) o nadzoru nad tobakom in okrogle mize na visoki ravni o nadzoru nad tobakom in razvojni politiki, ki je v organizaciji Komisije potekala 3. in 4. februarja 2003,
having regard to the World Health Organization (WHO) Framework Convention on Tobacco Control and the Commission's High-Level Round Table on Tobacco Control and Development Policy held on 3-4 February 2003,
ob upoštevanju svoje resolucije z dne 4. septembra 2003 o zdravju in zmanjševanju revščine v državah v razvoju UL C 76 E, 25.3.2004, str.
having regard to its resolution of 4 September 2003 on health and poverty reduction in developing countries OJ C 76 E, 25.03.2004, p.
ob upoštevanju resolucije, ki jo je sprejela skupna parlamentarna skupščina AKP-EU dne 19. februarja 2004 o boleznih, povezanih z revščino, in reproduktivnem zdravju (AKP-EU 3640/04),
having regard to the resolution adopted by the ACP-EU Joint Parliamentary Assembly on 19 February 2004 on poverty-related diseases and reproductive health (ACP-EU 3640/04),
ob upoštevanju poziva iz New Yorka: "Vzpostavimo povezavo med HIV /aidsom ter spolnim in reproduktivnim zdravjem" Poziv, objavljen po srečanju na visoki ravni, ki so ga pripravili Sklad OZN za prebivalstvo UNFPA, Agencija OZN za boj proti aidsu UNAIDS in organizacija Family Care International, New York, 7. junija 2004.
having regard to the New York Call to Commitment: Linking HIV/AIDS and Sexual and Reproductive Health Call to Commitment published at high level meeting organized by UNFPA, UNAIDS and Family Care International, New York 7 June 2004
ob upoštevanju svoje resolucije z dne 10. marca 2005 o znanosti in tehnologiji – smernice za prihodnjo politiko Evropske unije za podporo raziskovanju Sprejeta besedila, P6_TA(2005)0077 .
having regard to its resolution of 10 March 2005 on science and technology – Guidelines for future European Union policy to support research Texts Adopted, P6_TA(2005)0077 .
ob upoštevanju partnerstva evropskih držav in držav v razvoju za klinične poskuse (EDCTP, European and Developing Countries Clinical Trials Partnership), posebnega programa za raziskovanje in izobraževanje na področju tropskih bolezni (TDR, Special Programme for Research and Training in Tropical Diseases), globalne zveze za razvoj zdravil za zdravljenje tuberkuloze (TB Alliance), mednarodne pobude za cepivo proti aidsu (IAVI, International AIDS Vaccine Initiative), mednarodnega partnerskega sodelovanja na področju mikrobicidov (IPM, International Partnership for Microbicides), evropske pobude za cepivo proti malariji (EMVI, European Malaria Vaccine Initiative), Svetovnege zveze za cepiva in imunizacijo (GAVI, Global Alliance for Vaccines and Immunisation)/projekta za zdravila proti malariji (MMV, Medicines for Malaria Venture), pobude "Ustavimo malarijo" (Roll Back Malaria), pobude za zdravila za zapostavljene bolezni (DNDi, Drugs for Neglected Diseases Initiative) in drugih, ki raziskujejo in razvijajo zdravila za zapostavljene bolezni,
having regard to the European and Developing Countries Clinical Trials Partnership (EDCTP), Special Programme for Research and Training in Tropical Diseases (TDR), Global Alliance for TB Drug Development (TB Alliance), International AIDS Vaccine Initiative (IAVI), International Partnership for Microbicides (IPM), European Malaria Vaccine Initiative (EMVI), Global Alliance for Vaccines and Immunization (GAVI)/The Vaccine Fund, Medicines for Malaria Venture (MMV), Roll Back Malaria (RBM) Partnership and the Drugs for Neglected Diseases Initiative (DNDi) and others who are working to research and develop drugs for neglected diseases,
ob upoštevanju svoje resolucije z dne 12. aprila 2005 o vlogi Evropske unije pri doseganju razvojnih ciljev tisočletja (RCT) Sprejeta besedila, P6_TA(2005)0115 .
having regard to its resolution of 12 April 2005 on the role of the European Union in the achievement of the Millennium Development Goals (MDGs) Texts Adopted, P6_TA(2005)0115 .
ob upoštevanju poročila Projektne skupine v okviru razvojnega programa OZN o HIV/aidsu, malariji, tuberkulozi in dostopu do osnovnih zdravil v okviru načrta za doseganje razvojnih ciljev tisočletja z naslovom "Recept za zdrav razvoj: kako omogočiti širši dostop do zdravil", 2005,
having regard to the report of the UN Millennium Project Task Force on HIV/AIDS, Malaria, TB, and Access to Essential Medicines, "Prescription for Healthy Development: Increasing Access to Medicines", 2005,
ob upoštevanju poročila WHO o posebnem programu za farmacevtske raziskave in razvoj na področju zanemarjenih bolezni, objavljenem oktobra 2004, in poročila WHO o boljšem obvladovanju tropskih bolezni, predstavljenem na strateško-tehničnem srečanju WHO med 18. in 20. aprilom 2005 v Berlinu,
having regard to the WHO Paper on A Needs-Based Pharmaceutical R&D Agenda for Neglected Diseases, October 2004, and the WHO paper on the Intensified Control of Tropical Diseases presented at the WHO Strategic and Technical Meeting in Berlin, 18-20 April 2005,
ob upoštevanju poročila Odbora za razvoj ( A6-0215/2005 ),
having regard to the report of the Committee on Development ( A6-0215/2005 ),
ker medsebojna povezanost sveta, globalno segrevanje in pojav novih nevarnosti za zdravje, kot so ptičja gripa, virusa Ebola in Marburg, pojav starih nalezljivih bolezni, kot je TB, in širjenje v državah v razvoju bolezni, ki jih je mogoče preprečiti z cepljenjem, ter naraščajoča odpornost proti številnim zdravilom kažejo na potrebo po celovitem pristopu do vseh bolezni,
whereas the interconnection of the world, global warming and emerging health threats such as avian flu, Ebola and Marburg, the resurgence of old infectious diseases such as TB, the increased prevalence of vaccine-preventable diseases in developed countries and the growing problem of multi-drug resistance all show the need for a comprehensive approach to be taken to all diseases,
ker v Evropski uniji (EU) ni prave zavesti o tem, kako akutno je stanje teh bolezni, in ker se zaradi selitvenih tokov in vse številnejših potovanj povečuje tveganje, da se te bolezni razširijo,
whereas as there is a lack of sense of urgency in the European Union (EU), as migration and the increase in travel represent a growing risk of spreading these diseases,
ker si Svetovni sklad za boj proti aidsu, tuberkulozi in malariji prizadeva za zmanjšanje obsega bolezni in revščine in je koordinacija na področju načrtov in različnih akterjev bistvenega pomena, vključno z nabavo, razdeljevanje in ocenjevanje zdravil ter skladnost z nacionalnimi predpisi,
whereas the Global Fund to Fight AIDS, Tuberculosis and Malaria aims to reduce the burden of disease and poverty, and coordination between projects and players is crucial, including the procurement, distribution and evaluation of medicines and coherence with national protocols,
ker v svetu narašča število okuženih z HIV/aidsom, zlasti žensk in otrok, ker je leta 2004 število novih primerov okužbe preseglo vse meje iz prejšnjih let in ker cene antiretroviralnih zdravil (ARV) "vedno bolj ogrožajo javno zdravje" Poročilo o stanju podbude "3 milijone do leta 2005" WHO in UNAIDS, december 2004.
whereas HIV/AIDS cases continue to grow globally, with women and children particularly affected, and with more new infections in 2004 than in any previous year; and whereas antiretroviral (ARV) prices are an "increasingly serious public health hazard" WHO and UNAIDS "3 by 5" progress report, December 2004.
, saj so originalna zdravila do dvanajstkrat dražja kot najcenejša prvotna generična zdravila,
with second-line medicines up to twelve times more expensive than the most affordable first-line generics,
ker so vzroki za okužbe z HIV in aidsom, slabo zdravstveno stanje mater in slabo reproduktivno zdravje mnogokrat podobni in koreninijo v neenakopravnosti spolov, revščini, socialni marginalizaciji in ker spolno prenosljive bolezni dramatično povečujejo možnost za okužbo z HIV, zaradi ločene donatorske politike pa prihaja do povsem ločenih programov in njihove izvedbe,
whereas both HIV/AIDS and maternal and reproductive ill-health are driven by many common root causes, including gender inequality, poverty and social marginalisation, and whereas the presence of sexually transmitted diseases dramatically increases vulnerability to HIV infection, yet separate donor policy translates into divided programme delivery,
ker je preventiva najučinkovitejši način boja proti spolno prenosljivim boleznim (SPB), tudi okužbi s HIV/aidsom; ker obstaja očitna povezava med spolnim in reproduktivnim zdravjem in bojem proti okužbo s HIV/aidsom,
whereas prevention is the most effective way to fight sexually transmitted diseases (STDs), including HIV/AIDS, and there is a clear link between sexual and reproductive health and the fight against HIV/AIDS,
ker igra dostop do informacij in storitev s področja zdravja mater in reproduktivnega zdravja pomembno vlogo v odpravljanju revščine in bi moral predstavljati sestavni del boja proti HIV/aidsu,
whereas access to maternal and reproductive health information and services plays an important role in poverty reduction and should be integral to the fight against HIV/AIDS,
ker preprečevanje malarije zahteva uporabo z insekticidom prepojenih mrež proti komarjem (zlasti za majhne otroke, nosečnice in okužene z HIV/aidsom), zdravil proti malariji za nosečnice in insekticidnih razpršil z dolgotrajnim delovanjem v notranjih prostorih,
whereas the prevention of malaria requires the use of insecticide-treated mosquito nets (especially by young children, pregnant women and those living with HIV/AIDS), anti-malarial drugs for pregnant women and indoor residual spraying,
ker tuberkuloza prizadeva kar tretjino svetovnega prebivalstva – leta 2002 sta zaradi nje umrla približno dva milijona ljudi, med njimi številni okuženi z HIV/aidsom – in bi z novimi diagnostičnimi testi in zdravili to nesrečno svetovno epidemijo lahko omejili,
whereas TB affects one-third of the world's people, and in 2002 caused some two million deaths, many linked to HIV/AIDS, and new diagnostic tests and drugs could tackle this enormous global scourge,
ker se shistosomoza lahko zdravi s prazikvantelom, čeprav predstavljajo stroški kemoterapije le še dodatno breme za zdravstvene sisteme in istočano obstaja možnost pojava na zdravila odpornih zajedalcev, zaradi česar je treba razviti druga učinkovita zdravila,
whereas schistosomiasis can be treated by the drug praziquantel, but the associated cost of chemotherapy is an additional burden on health systems and there are concerns about the emergence of drug-resistant parasites, so there is a need to develop other effective remedies,
ker se stanje bolnika s hudo visceralno lišmaniozo in aidsom skupaj še hitreje poslabšuje, zdravljenje s petvalentnim antimonom pa ima hude stranske učinke, je dolgotrajno in vedno manj učinkovito zaradi odpornosti zajedalca,
whereas severe visceral leishmaniasis and AIDS reinforce one another but the treatment pentavalent antimony has serious side effects, requires a lengthy treatment and is losing efficacy due to parasite resistance,
ker diagnoza in zdravljenje afriške tripanosomioze ali spalne bolezni nista preprosta,
whereas the diagnosis and treatment of human African trypanosomiasis (HAT) or sleeping sickness is difficult,
ker lahko akutno obliko južnoameriške tripanosomioze (šagasa) zdravimo le z dvema zdraviloma, nifurtimoksom in benznidazolom, za kronično obliko pa ni zdravila,
whereas the acute phase of Chagas' disease can be treated by only two drugs, nifurtimox and benznidazole, while for the chronic phase there is no treatment,
ker mrzlica denga ogroža zdravje na svetovni ravni in se je komar Aedes albopictus, sekundarni prenašalec mrzlice denga v Aziji, zaradi mednarodne trgovine z rabljenimi pnevmatikami pojavil tudi v Evropi in drugih državah; ker pri tem posebnega zdravljenja ni, kljub temu da je dosežen napredek pri celostnem upravljanju z vektorji za širjenje bolezni, čeprav je razvoj cepiv počasen,
whereas dengue is a global health concern and Aedes albopictus, a secondary dengue vector in Asia, is now established in Europe and other regions, due to the international used tyre trade; and there is no specific treatment but progress is being made in integrated vector management while the development of vaccines is slow,
ker razjeda buruli v vedno večji meri ogroža zdravje, odpravimo pa jo lahko le operacijsko z odstranitvijo lezije, ki povzroča izgubo tkiva ali trajno invalidnost,
whereas Buruli ulcer is an emerging health threat and can only be treated by surgery to remove the lesion, causing loss of tissue or permanent disability,
ker je vedno več duševnih bolezni in epilepsije, ki pa so pogosto zapostavljene,
whereas the burden of mental illnesses and epilepsy is growing and neglected,
ker v številnih predelih tretjega sveta hudo primanjkuje zdravstvenih delavcev, migracijski tokovi pa potekajo tako iz kot znotraj revnejših pokrajin,
whereas there is a grave shortage of health workers in many parts of the developing world, with migration both from and within poorer regions,
ker obstaja ocena, da je leta 2000 zaradi ponovne uporabe zdravniških pripomočkov prišlo do približno 260 000 novih primerov okužbe s HIV/aidsom, 2 milijonov primerov okužbe s hepatitisom C in 21 milijonov primerov okužbe s hepatitisom B,
whereas re-used medical devices led to an estimated 260,000 new cases of HIV/AIDS, 2 million hepatitis C infections and 21 million hepatitis B infections in 2000,
ker na svetu zaradi uporabe tobaka vsako leto umre 5 milijonov ljudi in obstaja nevarnost, da se do leta 2020 ta številka podvoji, pri čemer bodo najbolj prizadete države v razvoju,
whereas 5 million deaths worldwide are caused annually by tobacco use and this could double by 2020, with the majority occurring in developing countries,
ker je premalo naložb v mednarodne in regionalne raziskave zdravil za bolezni, povezane z revščino,
whereas there is a chronic lack of investment in international and regional research in drugs for poverty-related diseases,
ker obstaja ocena, da se za spopadanje s problemi, ki sprožajo kar 90 % vseh bolezni na svetu, za biomedicinske raziskave namenja manj kot 10 % svetovnih sredstev in da je bilo med vsemi zdravili, ki so jih v obdobju 1999-2000 razvili za zanemarjene bolezni, 18 razvojno-raziskovalnih projektov na stopnji kliničnega razvoja, v primerjavi z 2.100 projekti, ki so se ukvarjali s sestavinami za vse ostale bolezni in da znaša čas za klinični razvoj za zanemarjene bolezni približno za tri leta in pol dlje kot za vse ostala stanja,
whereas it is estimated that less than 10% of the world's biomedical research funds are dedicated to addressing problems that are responsible for 90% of the world's burden of disease and that, of all drugs in development for all neglected diseases in 1999-2000, 18 R&D projects were in clinical development, compared with 2,100 compounds for all other diseases, and the mean time for clinical development for neglected diseases is about three and a half years more than for other conditions,
ker je bil dosežen znanstven napredek, vključno z določitvijo zaporedja nukleotidov v genomu zajedalcev, ki povzročajo malarijo, lišmaniozo in afriško tripanosomiozo, vendar se ga še ne upošteva pri izdelavi novih zdravil,
whereas scientific advances have been made, including the genome sequencing of parasites causing malaria, leishmaniasis and HAT, but these are not being translated into new products,
ker predstavlja projekt WHO za vpis zdravil na prednostni seznam (WHO Prequalification Project) pomembno mrežo za ocenjevanje in zagotavljanje novih temeljnih zdravil,
whereas the WHO Prequalification Project is an important network for assessing and procuring new essential medicines,
ker vsako leto za posledicami bolezni, ki se lahko preprečijo s cepljenjem, umre približno milijon in pol otrok,
whereas yearly an estimated one and a half million children under five die from vaccine-preventable diseases,
ker je v okviru določil Uredbe Sveta (ES) št. 953/2003 z dne 26. maja 2003 za preprečevanje preusmerjanja trgovine nekaterih ključnih zdravil v Evropsko unijo UL L 135, 3.6.2003, str.
whereas only one pharmaceutical company has registered medicines available at reduced prices under Council Regulation (EC) No 953/2003 of 26 May 2003 to avoid trade diversion into the EU of certain key medicines OJ L 135, 3.6.2003, p.
Uredba, kakor je bila spremenjena z Uredbo Komisije (ES) št. 1876/2004 (UL L 326, 29.10.2004, str.
Regulation as amended by Commission Regulation (EC) No 1876/2004 (OJ L 326, 29.10.2004, p.
, samo ena farmacevtska družba registrirala zdravila po znižani ceni; ker nova, danes nujna, a draga zdravila niso vključena na ta seznam,
; whereas new medicines necessary today, but available only at high prices, are not included in this list,
ker bi morale vse države članice Svetovne trgovinske organizacije (WTO) sporazum o trgovinskih vidikih pravic intelektualne lastnine TRIPS vključiti v nacionalne zakonodaje, kar zlasti velja za države, ki izdelujejo generična zdravila,
whereas all World Trade Organization (WTO) Member States should have integrated the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement into their national legislation, particularly States which produce generic medicines,
pozdravlja zgoraj navedeno sporočilo Komisije, vendar poziva k razširitvi njenega pristopa na druge zapostavljene bolezni; poudarja, da se lahko ukrepi Komisije uporabljajo tudi za druge bolezni, ne le za HIV/aids, malarijo in tuberkulozo;
Welcomes the Commission's above-mentioned communications, but calls for its approach to be broadened to include other neglected diseases; highlights the fact that the Commission's actions can all be applied to other diseases beyond HIV/AIDS, malaria and TB;
poziva Komisijo, da poskrbi za konkretno izvedbo predlogov političnih smernic v okviru novega akcijskega programa za boj proti HIV/aidsu, malariji in tuberkulozi, in sicer z sprejetjem ustreznih sklepov v zvezi s programom in zagotovitvijo proračunskih sredstev;
Urges the Commission to translate the policy proposals of the new Programme for Action to confront HIV/AIDS, TB and Malaria into concrete action by ensuring appropriate programming decisions and sufficient budget allocations;
poudarja izreden pomen zagotavljanja vedno večjih in zadostnih finančnih sredstev s strani držav članic in financiranja zunanjih dejavnosti EU in razvojne pomoči, saj bo samo za HIV/aids, malarijo in tuberkulozo do leta 2007 primanjkovalo 11 500 milionov EUR;
Stresses the critical importance of securing increased and adequate financial resources from Member States and in the funding of the EU's External Actions and development aid given that the resource gap for HIV/AIDS, malaria and TB alone is projected to reach EUR 11 500 million by 2007;
poziva Komisijo, da v okviru instrumentov zunanje pomoči prihodnje finančne perspektive problematiko HIV/aidsa, malarije, tuberkuloze in drugih bolezni obravnava kot večplastno;
Calls on the Commission to address HIV/AIDS, TB, malaria and other diseases as cross-cutting issues in the external assistance instruments of the next financial perspectives;
podpira oblikovanje solidarnostnega sklada Evropske unije ( KOM(2005)0108 ), ki naj postane instrument skupnega učinkovitega in usklajenega odzivanja na različne izredne razmere ne glede na njihov izvor;
Supports the establishment of the European Union Solidarity Fund ( COM(2005)0108 ) in order to provide a common response to emergency situations of different origin in an efficient and coordinated way;
opozarja na hude težave, s katerimi so se med letoma 1990 in 2000 srečevale zdravstvene službe v državah AKP zaradi poudarka na makro-ekonomskih reformah, ki so imele za posledico drastično znižanje proračunskih sredstev za sektorje s področja sociale, vključno z zdravstvom;
Recalls that health services in the ACP countries suffered greatly in the 1990s, particularly as a result of the emphasis placed on macro-economic reforms which led to drastic budget cuts in social sectors such as health;
opozarja, da vračanje dolgov skupaj s tem povezani stroški v najmanj razvitih državah predstavljajo skoraj 40 % BDP na leto, medtem ko so proračunska sredstva za izobraževanje in zdravstvo zanemarljiva;
Recalls also that repayment and servicing of the debt accounts for almost 40% of GDP per annum in the least developed countries, while education and health budgets are still derisory;
spodbuja države AKP, da izpolnijo cilj Evropskega parlamenta in 20 % sredstev namenijo za zdravje;
Urges ACP countries to meet Parliament's target of allocating 20% to health;
meni, da morajo dokumenti strategije za zmanjševanje revščine zagotoviti, da bo analiza revščine, na kateri temeljijo, vplivala na usmerjenost dela v zdravstvenem sektorju in zagotovila možnost za preusmeritev zdravstvenih načrtov in strategij k tistim zdravstvenim ukrepom, ki bodo najverjetneje vplivali na zmanjševanje revščine;
Believes that Poverty Reduction Strategy Papers must ensure that the poverty analysis that informs them influence the focus of work in the health sector and provide the opportunity to reorientate health plans and strategies to those health actions most likely to impact on poverty;
poudarja, da je dostop do pitne vode in hrane bistveni pogoj za zdravje prebivalstva; zato vztraja na dejstvu, da so zdravje in boljši življenjski pogoji medsebojno povezani dejavniki, ki pripomorejo k daljši življenjski dobi;
Stresses that access to drinking water and food is an essential condition for healthy populations; insists therefore on the cross dimension of health and the improvement of living conditions which contributes to increasing life expectancy;
poziva države v razvoju, da ponovno vzpostavijo sistem osnovnega javnega zdravstva in storitev, EU pa poziva, da pri tem nudi pomoč tako pri vzpostavljanju struktur kot večanju človeških in institucionalnih zmogljivosti in infrastrukture;
Calls on developing countries to restore their public and basic health care systems and services and for the EU to support this process through aid for the emergence and reinforcement of human and institutional capacities and infrastructures;